To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

• Status: Completed
• Trial end date: 2021-07-27
• Target enrollment: 0
• Participant gender: Male

Summary

An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and nebivolol or Paroxetine in healthy volunteers

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Daewoong Pharmaceutical Co. LTD.
• Treatments: Nebivolol; Paroxetine

Criteria

Inclusion Criteria:

• Healthy male adults aged ≥ 20 and ≤ 55 years at screening

• Subjects who voluntarily decided to participate in the study and provided written consent to follow study compliance requirements after receiving a detailed explanation on this study and fully understanding the information

Exclusion Criteria:

• Subjects unable to have the standard meal provided at the study site

• Subjects who took (the day of taking the last dose) another investigational or bioequivalence study product within 180 days prior to the first dose